This is the protocol for a review and there is no abstract. The objectives are as follows:, I. To determine the effect of hydralazine (as either monotherapy or in combination therapy) on:, (a) mortality, (b) morbidity, (c) systolic and diastoic blood pressure, compared to placebo and other antihypertensives in adults (of varying age, gender and race) with essential hypertension (with and without co-morbidity)., II. To determine whether hydralazine is associated with an increased incidence of adverse effects compared to placebo and other antihypertensive agents